Literature DB >> 19710046

Incidence of amyotrophic lateral sclerosis in Europe.

Giancarlo Logroscino1, Bryan J Traynor, Orla Hardiman, Adriano Chiò, Douglas Mitchell, Robert J Swingler, Andrea Millul, Emma Benn, Ettore Beghi.   

Abstract

BACKGROUND: Geographical differences in the incidence of amyotrophic lateral sclerosis (ALS) have been reported in the literature but comparisons across previous studies are limited by different methods in case ascertainment and by the relatively small size of the studied populations. To address these issues, the authors undertook a pooled analysis of European population based ALS registries.
METHODS: All new incident ALS cases in subjects aged 18 years old and older were identified prospectively in six population based registries in three European countries (Ireland, UK and Italy) in the 2 year period 1998-1999, with a reference population of almost 24 million.
RESULTS: Based on 1028 identified incident cases, the crude annual incidence rate of ALS in the general European population was 2.16 per 100 000 person years; 95% CI 2.0 to 2.3), with similar incidence rates across all registries. The incidence was higher among men (3.0 per 100 000 person years; 95% CI 2.8 to 3.3) than among women (2.4 per 100 000 person years; 95% CI 2.2 to 2.6). Spinal onset ALS was more common among men compared with women, particularly in the 70-80 year age group. Disease occurrence decreased rapidly after 80 years of age.
CONCLUSIONS: ALS incidence is homogeneous across Europe. Sex differences in incidence may be explained by the higher incidence of spinal onset ALS among men, and the age related disease pattern suggests that ALS occurs within a susceptible group within the population rather than being a disease of ageing.

Entities:  

Mesh:

Year:  2009        PMID: 19710046      PMCID: PMC2850819          DOI: 10.1136/jnnp.2009.183525

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study.

Authors:  Adriano Chiò; Giovannino Ciccone; Andrea Calvo; Marco Vercellino; Nicoletta Di Vito; Paolo Ghiglione; Roberto Mutani
Journal:  J Clin Epidemiol       Date:  2002-07       Impact factor: 6.437

Review 2.  The epidemiology of ALS and the role of population-based registries.

Authors:  Ettore Beghi; Giancarlo Logroscino; Adriano Chiò; Orla Hardiman; Douglas Mitchell; Robert Swingler; Bryan J Traynor
Journal:  Biochim Biophys Acta       Date:  2006-09-29

Review 3.  Ethnic variation in the incidence of ALS: a systematic review.

Authors:  Simon Cronin; Orla Hardiman; Bryan J Traynor
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

4.  Incidence of ALS in Lombardy, Italy.

Authors:  E Beghi; A Millul; A Micheli; E Vitelli; G Logroscino
Journal:  Neurology       Date:  2007-01-09       Impact factor: 9.910

5.  Incidence of ALS in Italy: evidence for a uniform frequency in Western countries.

Authors: 
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

Review 6.  Breaking the news in amyotrophic lateral sclerosis.

Authors:  Adriano Chiò; Gian Domenico Borasio
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2004-12

7.  Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O M Hardiman
Journal:  Arch Neurol       Date:  2000-08

8.  Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

Authors:  G Logroscino; E Beghi; S Zoccolella; R Palagano; A Fraddosio; I L Simone; P Lamberti; V Lepore; L Serlenga
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

9.  Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study.

Authors:  L M L de Lau; P C L M Giesbergen; M C de Rijk; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

10.  Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study.

Authors:  T Zaldivar; J Gutierrez; G Lara; M Carbonara; G Logroscino; O Hardiman
Journal:  Neurology       Date:  2009-05-12       Impact factor: 9.910

View more
  207 in total

Review 1.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 3.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 4.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

5.  Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Authors:  Adriano Chiò; Giuseppe Borghero; Maura Pugliatti; Anna Ticca; Andrea Calvo; Cristina Moglia; Roberto Mutani; Maura Brunetti; Irene Ossola; Maria Giovanna Marrosu; Maria Rita Murru; Gianluca Floris; Antonino Cannas; Leslie D Parish; Paola Cossu; Yevgeniya Abramzon; Janel O Johnson; Michael A Nalls; Sampath Arepalli; Sean Chong; Dena G Hernandez; Bryan J Traynor; Gabriella Restagno
Journal:  Arch Neurol       Date:  2011-01-10

6.  Fulminant amyotrophic lateral sclerosis manifesting in a young woman during pregnancy.

Authors:  Yuliia Solodovnikova; Anastasiia Kobryn; Alina Ivaniuk; Anatoliy Son
Journal:  Neurol Sci       Date:  2021-03-10       Impact factor: 3.307

Review 7.  Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.

Authors:  Dzung Do-Ha; Yossi Buskila; Lezanne Ooi
Journal:  Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.590

8.  Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Authors:  Angela Rosenbohm; Mingsheng Liu; Gabriele Nagel; Raphael S Peter; Bo Cui; Xiaoguang Li; Jan Kassubek; Dietrich Rothenbacher; Dorothée Lulé; Liying Cui; Albert C Ludolph
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

Review 9.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

10.  Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.

Authors:  Mohamed Kazamel; Gary Cutter; Gwendolyn Claussen; Mohammad Alsharabati; Shin J Oh; Liang Lu; Peter H King
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-03-05       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.